Home » Topics » BioWorld Science

BioWorld Science
RSS

Devacade shown to enhance pain relief in phase II clinical trial

Sep. 3, 2001

Dimethaid highlights Pennsaid progress during fiscal 2001

Sep. 3, 2001

Clinical programs at NPS continue steady progression during Q2

Sep. 3, 2001

Study questions cardiovascular safety of COX-2 inhibitors

Sep. 3, 2001

Uriach identifies UR-8880, its lead COX-2 inhibitor as a preclinical candidate

Aug. 31, 2001

Mitsubishi highlights their anti-H. pylori candidate at the ACS meeting

Aug. 31, 2001

Alcon presents potential antiglaucoma 13-oxaprostaglandins at the ACS meeting

Aug. 31, 2001

Neuropeptide Y antagonists designed at Fujisawa

Aug. 31, 2001

Sanofi-Synthelabo discloses PDE5 inhibitors and their use

Aug. 31, 2001

Sumitomo claims compounds useful for neuroretinal degenerative diseases

Aug. 31, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...